Salmonella Species

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Volumn 2, Issue , 2014, Pages 2559-2568

  Pegues, David A ^a,b,c   Miller, Samuel I ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Healthcare Epidemiology Infection Prevention and Control   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antibiotic resistance; Arizona infections; Bacteremia; Carrier state; Foodborne infections; Gastroenteritis; Immunity; Macrophages; Multidrug resistance; Nontyphoidal Salmonella; Opportunistic infections; Quinolone resistance; Travel associated infections; Typhoid fever

Indexed keywords

EID: 84944556507     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-4801-3.00225-3     Document Type: Chapter

References (208)

1. Smith T The hog-cholera group of bacteria. US Bur Anim Ind Bull 1894, 6:6-40.
2. Kauffman F The Diagnosis of Salmonella Types 1950, Charles C Thomas, Springfield, IL.
3. Zinder ND, Lederberg J Genetic exchange in Salmonella. J Bacteriol 1952, 64:679-699.
4. Ames BN, Lee FD, Durston WE An improved bacterial test system for detection and classification of mutagens and carcinogens. Proc Natl Acad Sci U S A 1973, 70:782-786.
5. Popoff MY, Bockemuhl J, Gheesling LL Supplement 2002 (no. 46) to the Kauffmann-White scheme. Res Microbiol 2004, 155:568-570.
6. Brenner FW, Villar RG, Angulo FJ, et al. Salmonella nomenclature. J Clin Microbiol 2000, 38:2465-2467.
7. Kidgell C, Reichard U, Wain J, et al. Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000 years old. Infect Genet Evol 2002, 2:39-45.
8. McClelland M, Sanderson KE, Clifton SW, et al. Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet 2004, 36:1268-1274.
9. Holt KE, Thomson NR, Wain J, et al. Pseudogene accumulation in the evolutionary histories of Salmonella enterica serovars Paratyphi A and Typhi. BMC Genomics 2009, 10:36.
10. Okoro CK, Kingsley RA, Connor TR, et al. Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nature Genet 2012, 44:1215-1221.
11. Farmer JJ, Boatwright KD, Janda JM Enterobacteriaceae: introduction and identification. Manual of Clinical Microbiology 2007, American Society for Microbiology, Washington, DC. 9th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen (Eds.).
12. Perez JM, Cavalli P, Roure C, et al. Comparison of four chromogenic media and Hektoen agar for detection and presumptive identification of Salmonella strains in human stools. J Clin Microbiol 2003, 41:1130-1134.
13. Church DL, Emshey D, Lloyd T, Pitout J Clinical and economic evaluation of BBL CHROMagar Salmonella (CHROMSal) versus subculture after selenite broth enrichment to CHROMSal and Hektoen enteric agars to detect enteric Salmonella in a large regional microbiology laboratory. Diagn Microbiol Infect Dis 2010, 68:13-19.
14. Ruiz J, Nunez ML, Diaz J, et al. Comparison of five plating media for isolation of Salmonella species from human stools. J Clin Microbiol 1996, 34:686-688.
15. Oracz G, Feleszko W, Golicka D, et al. Rapid diagnosis of acute Salmonella gastrointestinal infection. Clin Infect Dis 2003, 36:112-115.
16. Hein I, Flekna G, Krassnig M, Wagner M Real-time PCR for the detection of Salmonella spp. in food: an alternative approach to a conventional PCR system suggested by the FOOD-PCR project. J Microbiol Methods 2006, 66:538-547.
17. Daniels EM, Schneerson R, Egan WM, et al. Characterization of the Salmonella paratyphi C Vi polysaccharide. Infect Immun 1989, 57:3159-3164.
18. Humphries RM, Fang FC, Aarestrup FM, Hindler JA In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards. Clin Infect Dis 2012, 55:1107-1113.
19. Centers for Disease Control and Prevention Summary of notifiable diseases-United States, 2010. MMWR Morb Mortal Wkly Rep 2012, 59:1-111.
20. Centers for Disease Control and Prevention Foodborne Diseases Active Surveillance Network (FoodNet): FoodNet Surveillance Report for 2011 2012, U.S. Department of Health and Human Services, CDC, Atlanta.
21. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17:7-15.
22. Jones TF, Ingram LA, Cieslak PR, et al. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 2008, 198:109-114.
23. Hendriksen RS, Vieira AR, Karlsmose S, et al. Global monitoring of Salmonella serovar distribution from the World Health Organization Global Foodborne Infections Network Country Data Bank: results of quality assured laboratories from 2001 to 2007. Foodborne Pathog Dis 2011, 8:887-900.
24. Gradel KO, Dethlefsen C, Schonheyder HC, et al. Severity of infection and seasonal variation of non-typhoid Salmonella occurrence in humans. Epidemiol Infect 2007, 135:93-99.
25. Rodrigue DC, Tauxe RV, Rowe B International increase in Salmonella enteritidis: a new pandemic?. Epidemiol Infect 1990, 105:21-27.
26. Braden CR Salmonella enterica serotype Enteritidis and eggs: a national epidemic in the United States. Clin Infect Dis 2006, 43:512-517.
27. Humphrey T Salmonella Typhimurium definitive type 104. A multi-resistant Salmonella. Int J Food Microbiol 2001, 67:173-186.
28. Centers for Disease Control and Prevention Investigation Update: Multistate Outbreak of Human Salmonella Enteritidis Infections Associated with Shell Eggs Available at. http://www.cdc.gov/salmonella/enteritidis/.
29. Ebel E, Schlosser W Estimating the annual fraction of eggs contaminated with Salmonella enteritidis in the United States. Int J Food Microbiol 2000, 61:51-62.
30. Guard-Petter J, Henzler DJ, Rahman MM, Carlson RW On-farm monitoring of mouse-invasive Salmonella enterica serovar enteritidis and a model for its association with the production of contaminated eggs. Appl Environ Microbiol 1997, 63:1588-1593.
31. Baumler AJ, Hargis BM, Tsolis RM Tracing the origins of Salmonella outbreaks. Science 2000, 287:50-52.
32. White DG, Zhao S, Sudler R, et al. The isolation of antibiotic-resistant Salmonella from retail ground meats. N Engl J Med 2001, 345:1147-1154.
33. U.S.Department of Agriculture Progress Report on Salmonella and Campylobacter Testing of Raw Meat and Poultry Products, 1998-2011 Available at, Accessed June 21, 2014. http://www.fsis.usda.gov/wps/wcm/connect/f83a9981-4f9b-48da-a2a2-0b7effdc2edb/Progress_Report_Salmonella_Testing_1998-2011.pdf?MOD=AJPERES.
34. Parry SM, Palmer SR, Slader J, Humphrey T Risk factors for Salmonella food poisoning in the domestic kitchen-a case control study. Epidemiol Infect 2002, 129:277-285.
35. Sarwari AR, Magder LS, Levine P, et al. Serotype distribution of Salmonella isolates from food animals after slaughter differs from that of isolates found in humans. J Infect Dis 2001, 183:1295-1299.
36. Centers for Disease Control and Prevention Multistate outbreaks of Salmonella infections associated with raw tomatoes eaten in restaurants-United States, 2005-2006. MMWR Morb Mortal Wkly Rep 2007, 56:909-911.
37. Brooks JT, Rowe SY, Shillam P, et al. Salmonella Typhimurium infections transmitted by chlorine-pretreated clover sprout seeds. Am J Epidemiol 2001, 154:1020-1028.
38. Calhoun S, Post L, Warren B, et al. Prevalence and concentration of Salmonella on raw shelled peanuts in the United States. J Food Prot 2013, 76:575-579.
39. Sheth AN, Hoekstra M, Patel N, et al. A national outbreak of Salmonella serotype Tennessee infections from contaminated peanut butter: a new food vehicle for salmonellosis in the United States. Clin Infect Dis 2011, 53:356-362.
40. Cavallaro E, Date K, Medus C, et al. Salmonella typhimurium infections associated with peanut products. N Engl J Med 2011, 365:601-610.
41. Cahill SM, Wachsmuth IK, Costarrica Mde L, Ben Embarek PK Powdered infant formula as a source of Salmonella infection in infants. Clin Infect Dis 2008, 46:268-273.
42. Ryan CA, Nickels MK, Hargrett-Bean NT, et al. Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk. JAMA 1987, 258:3269-3274.
43. Mermin J, Hutwagner L, Vugia D, et al. Reptiles, amphibians, and human Salmonella infection: a population-based, case-control study. Clin Infect Dis 2004, 38(suppl 3):S253-S261.
44. Harris JR, Bergmire-Sweat D, Schlegel JH, et al. Multistate outbreak of Salmonella infections associated with small turtle exposure, 2007-2008. Pediatrics 2009, 124:1388-1394.
45. Finley R, Reid-Smith R, Weese JS Human health implications of Salmonella-contaminated natural pet treats and raw pet food. Clin Infect Dis 2006, 42:686-691.
46. Swanson SJ, Snider C, Braden CR, et al. Multidrug-resistant Salmonella enterica serotype Typhimurium associated with pet rodents. N Engl J Med 2007, 356:21-28.
47. Centers for Disease Control and Prevention National Antimicrobial Resistance Monitoring System: Enteric Bacteria 2010 Annual Report Available at. http://www.cdc.gov/narms/reports.html.
48. Chiu CH, Wu TL, Su LH, et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med 2002, 346:413-419.
49. Gordon MA, Graham SM, Walsh AL, et al. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 2008, 46:963-969.
50. Boyd EF, Hartl DL Recent horizontal transmission of plasmids between natural populations of Escherichia coli and Salmonella enterica. J Bacteriol 1997, 179:1622-1627.
51. Jones BD, Falkow S Identification and characterization of a Salmonella typhimurium oxygen-regulated gene required for bacterial internalization. Infect Immun 1994, 62:3745-3752.
52. Watson PR, Paulin SM, Bland AP, et al. Characterization of intestinal invasion by Salmonella typhimurium and Salmonella dublin and effect of a mutation in the invH gene. Infect Immun 1995, 63:2743-2754.
53. Dechet AM, Scallan E, Gensheimer K, et al. Outbreak of multidrug-resistant Salmonella enterica serotype Typhimurium Definitive Type 104 infection linked to commercial ground beef, northeastern United States, 2003-2004. Clin Infect Dis 2006, 42:747-752.
54. Varma JK, Molbak K, Barrett TJ, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005, 191:554-561.
55. Varma JK, Marcus R, Stenzel SA, et al. Highly resistant Salmonella Newport-MDRAmpC transmitted through the domestic US food supply: a FoodNet case-control study of sporadic Salmonella Newport infections, 2002-2003. J Infect Dis 2006, 194:222-230.
56. Boisrame-Gastrin S, Tande D, Munck MR, et al. Salmonella carriage in adopted children from Mali: 2001-08. J Antimicrob Chemother 2011, 66:2271-2276.
57. Winokur PL, Vonstein DL, Hoffman LJ, et al. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother 2001, 45:2716-2722.
58. Gupta A, Fontana J, Crowe C, et al. Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis 2003, 188:1707-1716.
59. Nordmann P, Poirel L, Mak JK, et al. Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants. Clin Infect Dis 2008, 46:324-325.
60. Olsen SJ, DeBess EE, McGivern TE, et al. A nosocomial outbreak of fluoroquinolone-resistant Salmonella infection. N Engl J Med 2001, 344:1572-1579.
61. Wadula J, von Gottberg A, Kilner D, et al. Nosocomial outbreak of extended-spectrum beta-lactamase-producing Salmonella isangi in pediatric wards. Pediatr Infect Dis J 2006, 25:843-844.
62. Wall PG, Ryan MJ Faecal incontinence in hospitals and residential and nursing homes for elderly people [letter; comment]. BMJ 1996, 312:378.
63. Occupationally acquired Salmonella I 4,12:i:1,2 infection in a phlebotomist-Minnesota, January 2013. MMWR Morb Mortal Wkly Rep 2013, 62:525.
64. Tauxe RV, Hassan LF, Findeisen KO, et al. Salmonellosis in nurses: lack of transmission to patients. J Infect Dis 1988, 157:370-373.
65. Wilson R, Feldman RA, Davis J, LaVenture M Salmonellosis in infants: the importance of intrafamilial transmission. Pediatrics 1982, 69:436-438.
66. Haddock RL, Cousens SN, Guzman CC Infant diet and salmonellosis. Am J Public Health 1991, 81:997-1000.
67. Bornemann R, Zerr DM, Heath J, et al. An outbreak of Salmonella serotype Saintpaul in a children's hospital. Infect Control Hosp Epidemiol 2002, 23:671-676.
68. Buchwald DS, Blaser MJ A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis 1984, 6:345-356.
69. Bowen A, Newman A, Estivariz C, et al. Role of acid-suppressing medications during a sustained outbreak of Salmonella enteritidis infection in a long-term care facility. Infect Control Hosp Epidemiol 2007, 28:1202-1205.
70. Blaser MJ, Neuman LS A review of human salmonellosis: I. Infective dose. Rev Infect Dis 1982, 4:1096.
71. Foster JW, Hall HK Adaptive acidification tolerance response of Salmonella typhimurium. J Bacteriol 1990, 172:771-778.
72. Michetti P, Mahan MJ, Slauch JM, et al. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 1992, 60:1786-1792.
73. Selsted ME, Miller SI, Henschen AH, Ouellette AJ Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biology 1992, 118:929-936.
74. van der Velden AW, Baumler AJ, Tsolis RM, Heffron F Multiple fimbrial adhesins are required for full virulence of Salmonella typhimurium in mice. Infect Immun 1998, 66:2803-2808.
75. Francis CL, Starnbach MN, Falkow S Morphological and cytoskeletal changes in epithelial cells occur immediately upon interaction with Salmonella typhimurium grown under low-oxygen conditions. Mol Microbiol 1992, 6:3077-3087.
76. Haraga A, West TE, Brittnacher MJ, et al. Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei. Infect Immun 2008, 76:5402-5411.
77. Scherer CA, Cooper E, Miller SI The Salmonella type III secretion translocon protein SspC is inserted into the epithelial cell plasma membrane upon infection. Mol Microbiol 2000, 37:1133-1145.
78. Hayward RD, Koronakis V Direct nucleation and bundling of actin by the SipC protein of invasive Salmonella. EMBO J 1999, 18:4926-4934.
79. Zhou D, Mooseker MS, Galan JE Role of the S. typhimurium actin-binding protein SipA in bacterial internalization. Science 1999, 283:2092-2095.
80. Hardt W-D, Chen L-M, Schuebel KE, et al. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 1998, 93:815-826.
81. Norris FA, Wilson MP, Wallis TS, et al. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci U S A 1998, 95:14057-14059.
82. Zhou D, Chen LM, Hernandez L, et al. A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol Microbiol 2001, 39:248-259.
83. Patel JC, Galan JE Differential activation and function of Rho GTPases during Salmonella-host cell interactions. J Cell Biol 2006, 175:453-463.
84. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361-367.
85. Vazquez-Torres A, Jones-Carson J, Baumler AJ, et al. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 1999, 401:804-808.
86. Watson PR, Galyov EE, Paulin SM, et al. Mutation of invH, but not stn, reduces Salmonella-induced enteritis in cattle. Infect Immun 1998, 66:1432-1438.
87. McCormick BA, Colgan SP, Delp-Archer C, et al. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J Cell Biol 1993, 123:895-907.
88. Eckmann L, Rudolf MT, Ptasznik A, et al. D-myo-Inositol 1,4,5,6-tetrakisphosphate produced in human intestinal epithelial cells in response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling pathways. Proc Natl Acad Sci U S A 1997, 94:14456-14460.
89. Prager R, Mirold S, Tietze E, et al. Prevalence and polymorphism of genes encoding translocated effector proteins among clinical isolates of Salmonella enterica. Int J Med Microbiol 2000, 290:605-617.
90. Akira S Mammalian Toll-like receptors. Curr Opin Immunol 2003, 15:5-11.
91. Miao EA, Alpuche-Aranda CM, Dors M, et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 2006, 7:569-575.
92. Sun Y, Overman SA, Thomas GJ Impact of in vitro assembly defects on in vivo function of the phage P22 portal. Virology 2007, 365:336-345.
93. Rubin RH, Weinstein L Salmonellosis: Microbiologic, Pathologic, and Clinical Features 1977, Stratton Intercontinental, New York.
94. Wilson RP, Raffatellu M, Chessa D, et al. The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol 2008, 10:876-890.
95. Fu Y, Galan JE A Salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 1999, 401:293-297.
96. Collier-Hyams LS, Zeng H, Sun J, et al. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol 2002, 169:2846-2850.
97. Haraga A, Miller SI A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. Infect Immun 2003, 71:4052-4058.
98. Winter SE, Thiennimitr P, Winter MG, et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010, 467:426-429.
99. Rubin FA, McWhirter PD, Burr D, et al. Rapid diagnosis of typhoid fever through identification of Salmonella typhi within 18 hours of specimen acquisition by culture of the mononuclear cell-platelet fraction of blood. J Clin Microbiol 1990, 28:825-827.
100. Fields PI, Swanson RV, Haidaris CG, Heffron F Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci U S A 1986, 83:5189-5193.
101. Richter-Dahlfors A, Buchan AMJ, Finlay BB Murine Salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J Exp Med 1997, 186:569-580.
102. Haraga A, Ohlson MB, Miller SI Salmonellae interplay with host cells. Nat Rev Microbiol 2008, 6:53-66.
103. Bader MW, Sanowar S, Daley ME, et al. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 2005, 122:461-472.
104. Prost LR, Daley ME, Bader MW, et al. The PhoQ histidine kinases of Salmonella and Pseudomonas spp. are structurally and functionally different: evidence that pH and antimicrobial peptide sensing contribute to mammalian pathogenesis. Mol Microbiol 2008, 69:503-519.
105. Prost LR, Miller SI The Salmonellae PhoQ sensor: mechanisms of detection of phagosome signals. Cell Microbiol 2008, 10:576-582.
106. Guo L, Lim K, Gunn JS, et al. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997, 276:250-253.
107. Prost LR, Sanowar S, Miller SI Salmonella sensing of anti-microbial mechanisms to promote survival within macrophages. Immunol Rev 2007, 219:55-65.
108. Hohmann EL, Oletta CA, Killeen KP, Miller SI phoP/phoQ-deleted Salmonella typhi (TY800) is a safe and immunogenic single dose typhoid fever vaccine in volunteers. J Infect Dis 1996, 173:1408-1414.
109. Looney RJ, Steigbigel RT Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro. J Lab Clin Med 1986, 108:506-516.
110. Shea JE, Hensel M, Gleeson C, Holden DW Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci U S A 1996, 93:2593-2597.
111. Brawn LC, Hayward RD, Koronakis V Salmonella SPI1 effector SipA persists after entry and cooperates with a SPI2 effector to regulate phagosome maturation and intracellular replication. Cell Host Microbe 2007, 1:63-75.
112. Ramsden AE, Mota LJ, Munter S, et al. The SPI-2 type III secretion system restricts motility of Salmonella-containing vacuoles. Cell Microbiol 2007, 9:2517-2529.
113. Ohlson MB, Huang Z, Alto NM, et al. Structure and function of Salmonella SifA indicate that its interactions with SKIP, SseJ, and RhoA family GTPases induce endosomal tubulation. Cell Host Microbe 2008, 4:434-446.
114. Christen M, Coye LH, Hontz JS, et al. Activation of a bacterial virulence protein by the GTPase RhoA. Sci Signal 2009, 2:ra71.
115. McLaughlin LM, Govoni GR, Gerke C, et al. The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migration. PLoS Pathog 2009, 5:e1000671.
116. Hicks SW, Charron G, Hang HC, Galan JE Subcellular targeting of Salmonella virulence proteins by host-mediated S-palmitoylation. Cell Host Microbe 2011, 10:9-20.
117. Meresse S, Unsworth KE, Habermann A, et al. Remodelling of the actin cytoskeleton is essential for replication of intravacuolar Salmonella. Cell Microbiol 2001, 3:567-577.
118. Miao EA, Brittnacher M, Haraga A, et al. Salmonella effectors translocated across the vacuolar membrane interact with the actin cytoskeleton. Mol Microbiol 2003, 48:401-415.
119. Lesnick ML, Reiner NE, Fierer J, Guiney DG The Salmonella spvB virulence gene encodes an enzyme that ADP-ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells. Mol Microbiol 2001, 39:1464-1470.
120. Rytkonen A, Poh J, Garmendia J, et al. SseL, a Salmonella deubiquitinase required for macrophage killing and virulence. Proc Natl Acad Sci U S A 2007, 104:3502-3507.
121. Thomas M, Holden DW Ubiquitination-a bacterial effector's ticket to ride. Cell Host Microbe 2009, 5:309-311.
122. Levin I, Eakin C, Blanc MP, et al. Identification of an unconventional E3 binding surface on the UbcH5 ~ Ub conjugate recognized by a pathogenic bacterial E3 ligase. Proc Natl Acad Sci U S A 2010, 107:2848-2853.
123. Salcedo SP, Holden DW SseG, a virulence protein that targets Salmonella to the Golgi network. EMBO J 2003, 22:5003-5014.
124. Fierer J, Krause M, Tauxe R, Guiney D Salmonella typhimurium bacteremia: association with the virulence plasmid. J Infect Dis 1992, 166:639-642.
125. Broz P, Ohlson MB, Monack DM Innate immune response to Salmonella typhimurium, a model enteric pathogen. Gut Microbes 2012, 3:62-70.
126. Bernheiden M, Heinrich JM, Minigo G, et al. LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection. J Endotoxin Res 2001, 7:447-450.
127. Lara-Tejero M, Sutterwala FS, Ogura Y, et al. Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J Exp Med 2006, 203:1407-1412.
128. Mastroeni P, Harrison JA, Robinson JH, et al. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun 1998, 66:4767-4776.
129. Everest P, Roberts M, Dougan G Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor. Infect Immun 1998, 66:3355-3364.
130. Hess J, Ladel C, Miko D, Kaufmann SH Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol 1996, 156:3321-3326.
131. Netea MG, Radstake T, Joosten LA, et al. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression. Arthritis Rheum 2003, 48:1853-1857.
132. Jouanguy E, Doffinger R, Dupuis S, et al. IL-12 and IFN-gamma in host defense against mycobacteria and Salmonella in mice and men. Curr Opin Immunol 1999, 11:346-351.
133. MacLennan CA, Gondwe EN, Msefula CL, et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest 2008, 118:1553-1562.
134. Gondwe EN, Molyneux ME, Goodall M, et al. Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci U S A 2010, 107:3070-3075.
135. Mastroeni P, Simmons C, Fowler R, et al. Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 2000, 68:46-53.
136. Nauciel C Role of CD4+ T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection. J Immunol 1990, 145:1265-1269.
137. Han T, Sokal JE, Neter E Salmonellosis in disseminated malignant diseases. A seven-year review (1959-1965). N Engl J Med 1967, 276:1045-1052.
138. Hsu RB, Lin FY Nontyphoid Salmonella infection in heart transplant recipients. Am J Med Sci 2008, 336:393-396.
139. Feasey NA, Dougan G, Kingsley RA, et al. Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012, 379:2489-2499.
140. Oksenhendler E, Gerard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008, 46:1547-1554.
141. Nencioni L, Villa L, De Magistris MT, et al. Cellular immunity against Salmonella typhi after live oral vaccine. Adv Exp Med Biol 1987, 216B:1669-1675.
142. Dunstan SJ, Stephens HA, Blackwell JM, et al. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis 2001, 183:261-268.
143. Saphra I, Winter JW Clinical manifestations of salmonellosis in man: an evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med 1957, 256:1128.
144. Abe K, Saito N, Kasuga F, Yamamoto S Prolonged incubation period of salmonellosis associated with low bacterial doses. J Food Prot 2004, 67:2735-2740.
145. Chaudhuri A, Bekdash BA Toxic megacolon due to Salmonella: a case report and review of the literature. Int J Colorectal Dis 2002, 17:275-279.
146. Lim E, Koh WH, Loh SF, et al. Non-typhoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 2001, 10:87-92.
147. Onwuezobe IA, Oshun PO, Odigwe CC Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev 2012, (11).
148. Szanton VL Epidemic salmonellosis. Pediatrics 1957, 20:794-808.
149. Mandal BK, Brennand J Bacteraemia in salmonellosis: a 15 year retrospective study from a regional infectious diseases unit. BMJ 1988, 297:1242-1243.
150. Brent AJ, Oundo JO, Mwangi I, et al. Salmonella bacteremia in Kenyan children. Pediatr Infect Dis J 2006, 25:230-236.
151. Chen PL, Chang CM, Wu CJ, et al. Extraintestinal focal infections in adults with nontyphoid Salmonella bacteraemia: predisposing factors and clinical outcome. J Intern Med 2007, 261:91-100.
152. Hsu RB, Tsay YG, Chen RJ, Chu SH Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 2003, 36:829-834.
153. Shimoni Z, Pitlik S, Leibovici L, et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis 1999, 28:822-827.
154. Gradel KO, Dethlefsen C, Schonheyder HC, Nielsen H Magnitude of bacteraemia is associated with increased mortality in non-typhoid salmonellosis: a one-year follow-up study. APMIS 2008, 116:147-153.
155. Yen YF, Lin YC, Chen TL, et al. Non-typhoidal Salmonella bacteremia in adults. J Microbiol Immunol Infect 2007, 40:227-233.
156. Cohen JI, Bartlett JA, Corey GR Extra-intestinal mani-festations of Salmonella infections. Medicine 1987, 66:349-388.
157. Benenson S, Raveh D, Schlesinger Y, et al. The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia. Am J Med 2001, 110:60-63.
158. Chen PL, Lee CC, Li CY, et al. A simple scoring algorithm predicting vascular infections in adults with nontyphoid Salmonella bacteremia. Clin Infect Dis 2012, 55:194-200.
159. Carey J, Buchstein S, Shah S Septic deep vein thrombosis due to Salmonella johannesburg. J Infect 2001, 42:79-80.
160. Arthur G, Nduba VN, Kariuki SM, et al. Trends in bloodstream infections among human immunodeficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade. Clin Infect Dis 2001, 33:248-256.
161. Gordon MA, Banda HT, Gondwe M, et al. Non-typhoidal Salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002, 16:1633-1641.
162. Gruenewald R, Blum S, Chan J Relationship between human immunodeficiency virus infection and salmonellosis in 20- to 59-year-old residents of New York City. Clin Infect Dis 1994, 18:358-363.
163. Gordon MA, Gordon SB, Musaya L, et al. Primary macrophages from HIV-infected adults show dysregulated cytokine responses to Salmonella, but normal internalization and killing. AIDS 2007, 21:2399-2408.
164. Hung CC, Hung MN, Hsueh PR, et al. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance. Clin Infect Dis 2007, 45:e60-e67.
165. Casado JL, Valdezate S, Calderon C, et al. Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients. J Infect Dis 1999, 179:1553-1556.
166. Musher DM, Rubenstein AD Permanent carriers of nontyphosa salmonellae. Arch Intern Med 1973, 132:869-872.
167. Stuart BM, Pullen RL Typhoid: clinical analysis of three hundred and sixty cases. Arch Intern Med 1946, 78:629-661.
168. Levine MM, Ferreccio C, Black RE, et al. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B. Clin Infect Dis 2007, 45(suppl 1):S24-S28.
169. Centers for Disease Control and Prevention CDC Health Information for International Travel 2012: The Yellow Book 2012, Oxford University Press, New York, NY.
170. Bhutta ZA Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006, 333:78-82.
171. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002, 347:1770-1782.
172. Ferreccio C, Morris JG, Valdivieso C, et al. Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers. J Infect Dis 1988, 157:1235.
173. Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 2004, 53:1-112.
174. Leibovitz E, Janco J, Piglansky L, et al. Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J 2000, 19:1060-1067.
175. Lightfoot NF, Ahmad F, Cowden J Management of institutional outbreaks of Salmonella gastroenteritis. J Antimicrob Chemother 1990, 26(suppl F):37-46.
176. Lao WF, Huang CH, Lin CH, et al. Endovascular stent graft repair for a Salmonella-infected aneurysm of thoracic aorta. Ann Vasc Surg 2012, 26:731.e5-731.e8.
177. Sirinavin S, Thavornnunth J, Sakchainanont B, et al. Norfloxacin and azithromycin for treatment of nontyphoidal Salmonella carriers. Clin Infect Dis 2003, 37:685-691.
178. Hulebak KL, Schlosser W Hazard analysis and critical control point (HACCP) history and conceptual overview. Risk Anal 2002, 22:547-552.
179. Swaminathan B, Gerner-Smidt P, Ng LK, et al. Building PulseNet International: an interconnected system of laboratory networks to facilitate timely public health recognition and response to foodborne disease outbreaks and emerging foodborne diseases. Foodborne Pathog Dis 2006, 3:36-50.
180. Okoro CK, Kingsley RA, Connor TR, et al. Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nature Genet 2012, 44:1215-1221.
181. Humphries RM, Fang FC, Aarestrup FM, Hindler JA In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards. Clin Infect Dis 2012, 55:1107-1113.
182. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17:7-15.
183. Centers for Disease Control and Prevention Investigation Update: Multistate Outbreak of Human Salmonella Enteritidis Infections Associated with Shell Eggs Available at. http://www.cdc.gov/salmonella/enteritidis/.
184. Cavallaro E, Date K, Medus C, et al. Salmonella typhimurium infections associated with peanut products. N Engl J Med 2011, 365:601-610.
185. Mermin J, Hutwagner L, Vugia D, et al. Reptiles, amphibians, and human Salmonella infection: a population-based, case-control study. Clin Infect Dis 2004, 38(suppl 3):S253-S261.
186. Chiu CH, Wu TL, Su LH, et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med 2002, 346:413-419.
187. Watson PR, Paulin SM, Bland AP, et al. Characterization of intestinal invasion by Salmonella typhimurium and Salmonella dublin and effect of a mutation in the invH gene. Infect Immun 1995, 63:2743-2754.
188. Varma JK, Molbak K, Barrett TJ, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005, 191:554-561.
189. Nordmann P, Poirel L, Mak JK, et al. Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants. Clin Infect Dis 2008, 46:324-325.
190. Francis CL, Starnbach MN, Falkow S Morphological and cytoskeletal changes in epithelial cells occur immediately upon interaction with Salmonella typhimurium grown under low-oxygen conditions. Mol Microbiol 1992, 6:3077-3087.
191. Rubin RH, Weinstein L Salmonellosis: Microbiologic, Pathologic, and Clinical Features 1977, Stratton Intercontinental, New York.
192. Winter SE, Thiennimitr P, Winter MG, et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010, 467:426-429.
193. Haraga A, Ohlson MB, Miller SI Salmonellae interplay with host cells. Nat Rev Microbiol 2008, 6:53-66.
194. Prost LR, Daley ME, Bader MW, et al. The PhoQ histidine kinases of Salmonella and Pseudomonas spp. are structurally and functionally different: evidence that pH and antimicrobial peptide sensing contribute to mammalian pathogenesis. Mol Microbiol 2008, 69:503-519.
195. Ramsden AE, Mota LJ, Munter S, et al. The SPI-2 type III secretion system restricts motility of Salmonella-containing vacuoles. Cell Microbiol 2007, 9:2517-2529.
196. Broz P, Ohlson MB, Monack DM Innate immune response to Salmonella typhimurium, a model enteric pathogen. Gut Microbes 2012, 3:62-70.
197. Netea MG, Radstake T, Joosten LA, et al. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression. Arthritis Rheum 2003, 48:1853-1857.
198. MacLennan CA, Gondwe EN, Msefula CL, et al. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest 2008, 118:1553-1562.
199. Gondwe EN, Molyneux ME, Goodall M, et al. Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci U S A 2010, 107:3070-3075.
200. Feasey NA, Dougan G, Kingsley RA, et al. Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012, 379:2489-2499.
201. Saphra I, Winter JW Clinical manifestations of salmonellosis in man: an evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med 1957, 256:1128.
202. Lim E, Koh WH, Loh SF, et al. Non-typhoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 2001, 10:87-92.
203. Mandal BK, Brennand J Bacteraemia in salmonellosis: a 15 year retrospective study from a regional infectious diseases unit. BMJ 1988, 297:1242-1243.
204. Hsu RB, Tsay YG, Chen RJ, Chu SH Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 2003, 36:829-834.
205. Yen YF, Lin YC, Chen TL, et al. Non-typhoidal Salmonella bacteremia in adults. J Microbiol Immunol Infect 2007, 40:227-233.
206. Chen PL, Lee CC, Li CY, et al. A simple scoring algorithm predicting vascular infections in adults with nontyphoid Salmonella bacteremia. Clin Infect Dis 2012, 55:194-200.
207. Musher DM, Rubenstein AD Permanent carriers of nontyphosa salmonellae. Arch Intern Med 1973, 132:869-872.
208. Centers for Disease Control and Prevention CDC Health Information for International Travel 2012: The Yellow Book 2012, Oxford University Press, New York, NY.